Michael T Charney, MD
Infectious Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 10 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
34 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Charney’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G22044 · Current
Licensed to practise in California · since 1972 · expires 2027-09-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$74,109
Medicare paid this office $74,109 for 192 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $26,874 | $103 |
| Return visit (30+ min) | 58 | $14,489 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,820 | $154 |
| New patient visit (45+ min) | 52 | $7,480 | $144 |
| Short return visit (20+ min) | 21 | $6,395 | $59 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $26,874 | $103 |
| Return visit (30+ min) | 58 | $14,489 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,820 | $154 |
| New patient visit (45+ min) | 52 | $7,480 | $144 |
| Short return visit (20+ min) | 21 | $6,395 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $3,101 | $70 |
Who their Medicare patients are
192 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 18% · Women 46% · Also on Medicaid 60% · Health risk score 2.38. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 56% · Coronary heart disease 35% · Chronic kidney disease 34% · Heart failure 27% · Atrial fibrillation 24% · Dementia 24% · COPD 23% · Depression 23% · Cancer 16% · Stroke 16%.
The office billed $121,317, Medicare allowed $97,202 and paid $74,109; for 715 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 192 | 715 | 74 | 2.38 | $121,317 | $74,109 |
| 2023 | 207 | 673 | 75 | 2.53 | $117,817 | $73,315 |
| 2022 | 236 | 885 | 76 | 2.61 | $151,609 | $93,700 |
| 2021 | 348 | 1,456 | 73 | 2.77 | $239,154 | $155,897 |
| 2020 | 468 | 2,000 | 74 | 2.99 | $326,313 | $210,705 |
| 2019 | 436 | 1,836 | 74 | 2.97 | $282,495 | $176,922 |
| 2018 | 520 | 2,530 | 73 | 2.96 | $365,885 | $217,050 |
| 2017 | 523 | 2,638 | 74 | 3.03 | $365,430 | $214,463 |
| 2016 | 462 | 2,210 | 74 | 2.82 | $321,800 | $188,747 |
| 2015 | 427 | 2,310 | 73 | 2.92 | $297,155 | $174,138 |
| 2014 | 468 | 2,944 | 73 | 2.65 | $384,885 | $222,969 |
| 2013 | 476 | 2,890 | 74 | 2.69 | $362,345 | $207,838 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $25,888 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $16,565 | $156 |
| Return visit (30+ min) | 53 | $14,816 | $111 |
| New patient visit (45+ min) | 42 | $5,637 | $134 |
| Short return visit (20+ min) | 12 | $3,755 | $60 |
2022: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $33,422 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 143 | $28,041 | $179 |
| Return visit (30+ min) | 58 | $11,741 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $5,581 | $65 |
| Short return visit (20+ min) | 27 | $4,504 | $79 |
| New patient visit (45+ min) | 19 | $2,814 | $148 |
| New patient visit (60+ min) | 14 | $2,598 | $186 |
2021: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 191 | $57,759 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 242 | $48,301 | $185 |
| Return visit (30+ min) | 61 | $11,876 | $118 |
| Short return visit (20+ min) | 23 | $11,749 | $63 |
| Short return visit (20+ min) | 46 | $8,803 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $6,506 | $66 |
| New patient visit (60+ min) | 27 | $5,298 | $196 |
| New patient visit (45+ min) | 11 | $1,627 | $148 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 12 | $757 | $63 |
| Administration of influenza virus vaccine | 12 | $262 | $22 |
2020: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 288 | $86,695 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 367 | $77,684 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $16,621 | $66 |
| Short return visit (20+ min) | 55 | $8,592 | $66 |
| Short return visit (20+ min) | 19 | $6,293 | $47 |
| Return visit (30+ min) | 56 | $6,275 | $86 |
| New patient visit (60+ min) | 13 | $2,471 | $190 |
| New patient visit (45+ min) | 17 | $2,356 | $139 |
| Return visit (30+ min) | 11 | $1,084 | $72 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 14 | $854 | $61 |
| Administration of influenza virus vaccine | 14 | $293 | $21 |
2019: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 301 | $60,682 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 231 | $54,743 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $24,952 | $65 |
| Short return visit (20+ min) | 77 | $11,602 | $61 |
| New patient visit (60+ min) | 41 | $7,007 | $171 |
| Return visit (30+ min) | 52 | $6,908 | $97 |
| Short return visit (20+ min) | 16 | $3,574 | $46 |
| New patient visit (45+ min) | 19 | $2,617 | $138 |
| Return visit (30+ min) | 17 | $1,275 | $71 |
2018: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 361 | $74,660 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 256 | $49,593 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $45,409 | $63 |
| Short return visit (20+ min) | 124 | $17,987 | $62 |
| New patient visit (60+ min) | 64 | $11,761 | $184 |
| Short return visit (20+ min) | 44 | $7,019 | $45 |
| Return visit (30+ min) | 19 | $2,093 | $91 |
| New patient visit (45+ min) | 17 | $1,901 | $112 |
| Return visit (30+ min) | 18 | $1,302 | $69 |
2017: 10 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 332 | $66,547 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 187 | $61,278 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 237 | $40,854 | $90 |
| New patient visit (60+ min) | 77 | $13,797 | $179 |
| Short return visit (20+ min) | 100 | $13,230 | $62 |
| Short return visit (20+ min) | 33 | $7,058 | $44 |
| Return visit (30+ min) | 24 | $2,591 | $81 |
| New patient visit (45+ min) | 20 | $2,196 | $110 |
| Administration of influenza virus vaccine | 14 | $452 | $32 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
2016: 11 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 316 | $61,977 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 173 | $52,982 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 202 | $36,017 | $89 |
| Short return visit (20+ min) | 97 | $13,736 | $58 |
| New patient visit (60+ min) | 38 | $6,384 | $168 |
| Short return visit (20+ min) | 30 | $5,471 | $44 |
| Return visit (30+ min) | 30 | $3,124 | $87 |
| Return visit (30+ min) | 25 | $2,220 | $67 |
| New patient visit (45+ min) | 17 | $1,883 | $111 |
| New patient visit (45+ min) | 12 | $1,752 | $146 |
| Administration of influenza virus vaccine | 11 | $348 | $32 |
2015: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 203 | $68,198 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 254 | $50,996 | $176 |
| Short return visit (20+ min) | 108 | $15,545 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $12,530 | $91 |
| New patient visit (60+ min) | 51 | $9,336 | $183 |
| Short return visit (20+ min) | 25 | $5,323 | $44 |
| New patient visit (45+ min) | 20 | $2,253 | $113 |
| New patient visit (45+ min) | 14 | $2,079 | $149 |
| Return visit (30+ min) | 24 | $1,918 | $71 |
| Return visit (30+ min) | 21 | $1,847 | $68 |
| Administration of influenza virus vaccine | 15 | $509 | $32 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 15 | $285 | $18 |
2014: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 257 | $107,668 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 291 | $59,897 | $180 |
| Short return visit (20+ min) | 122 | $21,684 | $62 |
| New patient visit (60+ min) | 52 | $9,319 | $179 |
| Short return visit (20+ min) | 42 | $8,686 | $44 |
| New patient visit (45+ min) | 35 | $4,046 | $116 |
| Return visit (30+ min) | 26 | $2,955 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,311 | $92 |
| Return visit (30+ min) | 24 | $2,237 | $66 |
| Administration of influenza virus vaccine | 14 | $436 | $31 |
2013: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 266 | $92,686 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 291 | $57,920 | $174 |
| Short return visit (20+ min) | 109 | $18,729 | $64 |
| New patient visit (60+ min) | 49 | $9,016 | $184 |
| Short return visit (20+ min) | 40 | $7,037 | $43 |
| New patient visit (45+ min) | 40 | $4,349 | $109 |
| Return visit (30+ min) | 43 | $4,260 | $91 |
| Return visit (30+ min) | 43 | $3,879 | $67 |
| New patient visit (45+ min) | 18 | $2,444 | $136 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,883 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,671 | $119 |
| Administration of influenza virus vaccine | 16 | $492 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 16 | $189 | $12 |
Medicaid work
$1,261 in 2024
Medicaid paid $1,261 for 165 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 152 | $899 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $362 |
| 2024 | 165 | 2 | 25 | $1,261 |
| 2023 | 248 | 3 | 22 | $3,041 |
| 2022 | 529 | 4 | 30 | $8,994 |
| 2021 | 1,527 | 4 | 37 | $45,544 |
| 2020 | 1,880 | 4 | 54 | $54,821 |
| 2019 | 1,407 | 4 | 41 | $43,140 |
| 2018 | 1,332 | 5 | 45 | $45,264 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 121 | $1,905 |
| Return visit (30+ min) | 81 | $586 |
| 1ST HOSP IP/OBS HIGH 75 | 46 | $550 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 424 | $6,759 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 31 | $1,416 |
| 1ST HOSP IP/OBS HIGH 75 | 43 | $719 |
| Short return visit (20+ min) | 31 | $101 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 973 | $28,485 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 206 | $14,882 |
| 1ST HOSP IP/OBS HIGH 75 | 91 | $1,831 |
| Short return visit (20+ min) | 257 | $346 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,375 | $34,558 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 249 | $16,927 |
| 1ST HOSP IP/OBS HIGH 75 | 193 | $2,800 |
| Short return visit (20+ min) | 63 | $536 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 931 | $24,440 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 258 | $15,458 |
| 1ST HOSP IP/OBS HIGH 75 | 115 | $2,603 |
| Short return visit (20+ min) | 103 | $640 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 668 | $20,700 |
| 1ST HOSP IP/OBS HIGH 75 | 313 | $12,857 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 80 | $5,742 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 204 | $5,697 |
| Short return visit (20+ min) | 67 | $268 |
Drugs they prescribed that Part D paid
$526,210
Pharmacies billed $526,210 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,025) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
885 generic and fewer than 11 brand-name prescriptions · $526,210 in drug cost · 293 antibiotic prescriptions to 102 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 47 | $178,180 | $3,791 |
| Odefsey | 22 | $84,958 | $3,862 |
| Genvoya | 21 | $80,968 | $3,856 |
| Efavirenz-Emtric-Tenofov Disop | 41 | $28,126 | $686 |
| Tivicay | 12 | $26,085 | $2,174 |
See all 28 drugs
| Biktarvy | 47 | $178,180 | $3,791 |
| Odefsey | 22 | $84,958 | $3,862 |
| Genvoya | 21 | $80,968 | $3,856 |
| Efavirenz-Emtric-Tenofov Disop | 41 | $28,126 | $686 |
| Tivicay | 12 | $26,085 | $2,174 |
| Efavirenz | 16 | $14,347 | $897 |
| Rifampin | 166 | $7,861 | $47 |
| Micafungin | 13 | $6,724 | $517 |
| Lamivudine | 17 | $5,921 | $348 |
| Fluconazole | 46 | $3,064 | $67 |
| Vancomycin | 22 | $2,594 | $118 |
| Ethambutol | 45 | $1,972 | $44 |
| Doxycycline Hyclate | 51 | $1,310 | $26 |
| Doxycycline Monohydrate | 25 | $1,029 | $41 |
| Valacyclovir | 23 | $697 | $30 |
| Azithromycin | 30 | $678 | $23 |
| Tenofovir Disoproxil | 17 | $574 | $34 |
| Ciprofloxacin | 45 | $519 | $12 |
| Isoniazid | 43 | $386 | $9 |
| Nitrofurantoin Mono-Macro | 18 | $343 | $19 |
| Amoxicillin-Clavulanate Potass | 19 | $319 | $17 |
| Cephalexin | 22 | $293 | $13 |
| Sulfamethoxazole-Trimethoprim | 31 | $190 | $6 |
| Erythromycin | 12 | $105 | $9 |
| Mupirocin | 12 | $104 | $9 |
| Acyclovir | 11 | $102 | $9 |
| Tamsulosin | 11 | $60 | $5 |
| Amoxicillin | 13 | $51 | $4 |
Year by year
| 2024 | 1,025 | 197 | 0% (0) | None | $526,210 |
| 2023 | 1,052 | 175 | 0% (0) | None | $478,416 |
| 2022 | 895 | 160 | 0% (0) | None | $367,204 |
| 2021 | 882 | 149 | 0% (0) | 12% | $482,774 |
| 2020 | 758 | 122 | None | 16% | $385,196 |
| 2019 | 798 | 147 | 0% (0) | 21% | $353,988 |
| 2018 | 969 | 162 | 0% (0) | None | $400,461 |
| 2017 | 915 | 148 | 0% (0) | 22% | $303,498 |
| 2016 | 915 | 149 | None | 23% | $277,997 |
| 2015 | 909 | 155 | None | 23% | $259,302 |
| 2014 | 905 | 147 | None | None | $217,782 |
| 2013 | 966 | 152 | 0% (0) | 22% | $201,186 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Biktarvy | 27 | $100,944 | $3,739 |
| Odefsey | 26 | $97,935 | $3,767 |
| Efavirenz-Emtric-Tenofov Disop | 52 | $61,763 | $1,188 |
| Genvoya | 14 | $57,454 | $4,104 |
| Tivicay | 12 | $28,693 | $2,391 |
| Efavirenz | 24 | $12,903 | $538 |
| Rifampin | 124 | $12,340 | $100 |
| Tenofovir Disoproxil | 24 | $10,999 | $458 |
| Lamivudine | 21 | $5,224 | $249 |
| Fluconazole | 53 | $4,363 | $82 |
| Emtricitabine-Tenofovir Disop | 16 | $3,890 | $243 |
| Azithromycin | 33 | $2,744 | $83 |
| Ethambutol | 51 | $2,708 | $53 |
| Vancomycin | 17 | $2,128 | $125 |
| Doxycycline Monohydrate | 51 | $1,706 | $33 |
| Valacyclovir | 19 | $1,445 | $76 |
| Cephalexin | 40 | $1,257 | $31 |
| Dapsone | 17 | $1,205 | $71 |
| Doxycycline Hyclate | 24 | $1,091 | $45 |
| Clarithromycin | 18 | $1,039 | $58 |
| Amoxicillin-Clavulanate Potass | 34 | $861 | $25 |
| Sulfamethoxazole-Trimethoprim | 48 | $790 | $16 |
| Isoniazid | 48 | $476 | $10 |
| Ciprofloxacin | 38 | $460 | $12 |
| Tamsulosin | 11 | $424 | $39 |
| Acyclovir | 12 | $322 | $27 |
| Amoxicillin | 25 | $262 | $10 |
| Losartan | 12 | $176 | $15 |
| Erythromycin | 12 | $152 | $13 |
2022: 27 drugs
| Biktarvy | 24 | $87,180 | $3,632 |
| Efavirenz-Emtric-Tenofov Disop | 43 | $57,096 | $1,328 |
| Genvoya | 14 | $54,107 | $3,865 |
| Odefsey | 13 | $45,210 | $3,478 |
| Efavirenz | 25 | $12,322 | $493 |
| Tenofovir Disoproxil | 24 | $10,539 | $439 |
| Rifampin | 87 | $8,459 | $97 |
| Pyrazinamide | 22 | $4,865 | $221 |
| Lamivudine | 24 | $4,599 | $192 |
| Voriconazole | 15 | $4,146 | $276 |
| Doxycycline Monohydrate | 39 | $2,597 | $67 |
| Valacyclovir | 19 | $2,554 | $134 |
| Fluconazole | 29 | $1,999 | $69 |
| Ethambutol | 38 | $1,640 | $43 |
| Azithromycin | 15 | $1,527 | $102 |
| Cephalexin | 61 | $1,125 | $18 |
| Amoxicillin-Clavulanate Potass | 24 | $1,102 | $46 |
| Clarithromycin | 19 | $1,084 | $57 |
| Dapsone | 14 | $952 | $68 |
| Clotrimazole | 11 | $673 | $61 |
| Doxycycline Hyclate | 11 | $660 | $60 |
| Clindamycin | 24 | $449 | $19 |
| Ciprofloxacin | 22 | $443 | $20 |
| Sulfamethoxazole-Trimethoprim | 30 | $427 | $14 |
| Isoniazid | 29 | $260 | $9 |
| Amoxicillin | 29 | $233 | $8 |
| Losartan | 12 | $128 | $11 |
2021: 27 drugs
| Biktarvy | 18 | $65,475 | $3,637 |
| Atripla | 21 | $64,121 | $3,053 |
| Efavirenz-Emtric-Tenofov Disop | 29 | $50,351 | $1,736 |
| Genvoya | 14 | $50,068 | $3,576 |
| Odefsey | 12 | $39,143 | $3,262 |
| Triumeq | 11 | $34,047 | $3,095 |
| Ertapenem | 24 | $22,099 | $921 |
| Efavirenz | 24 | $12,400 | $517 |
| Tenofovir Disoproxil | 24 | $10,514 | $438 |
| Lamivudine | 24 | $4,689 | $195 |
| Rifampin | 46 | $3,814 | $83 |
| Fluconazole | 30 | $3,254 | $108 |
| Doxycycline Monohydrate | 49 | $3,161 | $65 |
| Clarithromycin | 25 | $2,275 | $91 |
| Cephalexin | 63 | $1,453 | $23 |
| Azithromycin | 29 | $1,355 | $47 |
| Amoxicillin-Clavulanate Potass | 35 | $1,308 | $37 |
| Dapsone | 11 | $894 | $81 |
| Sulfamethoxazole-Trimethoprim | 77 | $884 | $11 |
| Doxycycline Hyclate | 19 | $760 | $40 |
| Ciprofloxacin | 25 | $403 | $16 |
| Ceftriaxone | 12 | $366 | $30 |
| Clindamycin | 15 | $247 | $16 |
| Losartan | 18 | $236 | $13 |
| Amoxicillin | 26 | $224 | $9 |
| Isoniazid | 18 | $207 | $12 |
| Acyclovir | 11 | $180 | $16 |
2020: 24 drugs
| Atripla | 34 | $105,072 | $3,090 |
| Genvoya | 19 | $61,156 | $3,219 |
| Biktarvy | 14 | $47,437 | $3,388 |
| Odefsey | 12 | $37,352 | $3,113 |
| Efavirenz | 26 | $16,945 | $652 |
| Ertapenem | 17 | $14,589 | $858 |
| Tenofovir Disoproxil | 25 | $11,909 | $476 |
| Vancomycin | 13 | $8,307 | $639 |
| Lamivudine | 26 | $7,553 | $291 |
| Fluconazole | 32 | $1,951 | $61 |
| Doxycycline Hyclate | 31 | $1,907 | $62 |
| Doxycycline Monohydrate | 28 | $1,849 | $66 |
| Amoxicillin-Clavulanate Potass | 36 | $1,646 | $46 |
| Rifampin | 24 | $1,596 | $66 |
| Azithromycin | 25 | $681 | $27 |
| Sulfamethoxazole-Trimethoprim | 46 | $652 | $14 |
| Clindamycin | 11 | $582 | $53 |
| Cephalexin | 28 | $532 | $19 |
| Ciprofloxacin | 24 | $467 | $19 |
| Nitrofurantoin Mono-Macro | 11 | $418 | $38 |
| Amoxicillin | 29 | $278 | $10 |
| Losartan | 23 | $257 | $11 |
| Isoniazid | 11 | $86 | $8 |
| Simvastatin | 11 | $69 | $6 |
2019: 27 drugs
| Atripla | 29 | $83,010 | $2,862 |
| Genvoya | 13 | $38,924 | $2,994 |
| Triumeq | 12 | $34,161 | $2,847 |
| Odefsey | 11 | $32,538 | $2,958 |
| Viread | 16 | $18,096 | $1,131 |
| Efavirenz | 13 | $9,711 | $747 |
| Vancomycin | 13 | $5,559 | $428 |
| Lamivudine | 16 | $4,151 | $259 |
| Tenofovir Disoproxil | 13 | $4,006 | $308 |
| Doxycycline Hyclate | 50 | $3,093 | $62 |
| Fluconazole | 41 | $2,818 | $69 |
| Rifampin | 40 | $2,452 | $61 |
| Amoxicillin-Clavulanate Potass | 36 | $1,926 | $53 |
| Dapsone | 13 | $1,403 | $108 |
| Clindamycin | 17 | $1,121 | $66 |
| Ethambutol | 18 | $977 | $54 |
| Doxycycline Monohydrate | 19 | $860 | $45 |
| Azithromycin | 24 | $709 | $30 |
| Sulfamethoxazole-Trimethoprim | 43 | $471 | $11 |
| Cephalexin | 26 | $435 | $17 |
| Ciprofloxacin | 19 | $412 | $22 |
| Acyclovir | 11 | $317 | $29 |
| Isoniazid | 34 | $285 | $8 |
| Amoxicillin | 22 | $235 | $11 |
| Tamsulosin | 12 | $147 | $12 |
| Losartan | 12 | $119 | $10 |
| Simvastatin | 12 | $67 | $6 |
2018: 27 drugs
| Atripla | 41 | $112,786 | $2,751 |
| Complera | 12 | $34,359 | $2,863 |
| Vancomycin | 38 | $19,510 | $513 |
| Prezista | 11 | $16,850 | $1,532 |
| Isentress | 11 | $15,990 | $1,454 |
| Intelence | 11 | $13,529 | $1,230 |
| Viread | 11 | $11,459 | $1,042 |
| Fluconazole | 66 | $4,294 | $65 |
| Rifampin | 42 | $2,556 | $61 |
| Amoxicillin-Clavulanate Potass | 68 | $2,230 | $33 |
| Nystop | 12 | $1,115 | $93 |
| Dapsone | 13 | $1,032 | $79 |
| Azithromycin | 33 | $963 | $29 |
| Doxycycline Hyclate | 29 | $914 | $32 |
| Clindamycin | 25 | $913 | $37 |
| Sulfamethoxazole-Trimethoprim | 49 | $854 | $17 |
| Cephalexin | 44 | $847 | $19 |
| Doxycycline Monohydrate | 16 | $818 | $51 |
| Ethambutol | 12 | $589 | $49 |
| Tamsulosin | 19 | $412 | $22 |
| Acyclovir | 20 | $400 | $20 |
| Amoxicillin | 35 | $341 | $10 |
| Isoniazid | 38 | $290 | $8 |
| Levofloxacin | 14 | $219 | $16 |
| Ciprofloxacin | 15 | $100 | $7 |
| Losartan | 12 | $95 | $8 |
| Pantoprazole | 12 | $22 | $2 |
2017: 32 drugs
| Atripla | 30 | $77,883 | $2,596 |
| Complera | 13 | $36,376 | $2,798 |
| Valganciclovir | 11 | $29,964 | $2,724 |
| Prezista | 15 | $20,711 | $1,381 |
| Isentress | 13 | $16,981 | $1,306 |
| Intelence | 13 | $14,375 | $1,106 |
| Viread | 13 | $13,405 | $1,031 |
| Norvir | 14 | $6,554 | $468 |
| Epivir | 11 | $4,299 | $391 |
| Fluconazole | 58 | $2,983 | $51 |
| Piperacillin-Tazobactam | 13 | $2,980 | $229 |
| Econazole Nitrate | 40 | $2,703 | $68 |
| Pyrazinamide | 11 | $2,685 | $244 |
| Rifampin | 41 | $2,474 | $60 |
| Doxycycline Hyclate | 52 | $1,930 | $37 |
| Cephalexin | 45 | $1,686 | $37 |
| Amoxicillin-Clavulanate Potass | 39 | $1,245 | $32 |
| Valacyclovir | 12 | $1,046 | $87 |
| Doxycycline Monohydrate | 22 | $875 | $40 |
| Azithromycin | 29 | $843 | $29 |
| Clotrimazole | 13 | $802 | $62 |
| Nitrofurantoin Mono-Macro | 15 | $794 | $53 |
| Clindamycin | 18 | $757 | $42 |
| Tamsulosin | 13 | $530 | $41 |
| Isoniazid | 43 | $257 | $6 |
| Sulfamethoxazole-Trimethoprim | 14 | $240 | $17 |
| Ciprofloxacin | 18 | $232 | $13 |
| Pantoprazole | 13 | $135 | $10 |
| Acyclovir | 18 | $121 | $7 |
| Amoxicillin | 17 | $110 | $6 |
| Losartan | 21 | $108 | $5 |
| Simvastatin | 15 | $75 | $5 |
2016: 31 drugs
| Prezista | 27 | $35,530 | $1,316 |
| Truvada | 12 | $17,612 | $1,468 |
| Isentress | 14 | $16,946 | $1,210 |
| Intelence | 14 | $14,350 | $1,025 |
| Viread | 11 | $10,992 | $999 |
| Norvir | 26 | $9,882 | $380 |
| Crixivan | 12 | $5,496 | $458 |
| Econazole Nitrate | 40 | $5,455 | $136 |
| Epivir | 12 | $4,314 | $360 |
| Fluconazole | 47 | $3,646 | $78 |
| Rifampin | 26 | $2,085 | $80 |
| Amoxicillin-Clavulanate Potass | 49 | $1,913 | $39 |
| Doxycycline Hyclate | 25 | $1,699 | $68 |
| Valacyclovir | 14 | $1,293 | $92 |
| Acyclovir | 20 | $1,229 | $61 |
| Azithromycin | 23 | $1,211 | $53 |
| Cephalexin | 48 | $1,137 | $24 |
| Doxycycline Monohydrate | 14 | $912 | $65 |
| Clindamycin | 23 | $766 | $33 |
| Mupirocin | 35 | $496 | $14 |
| Tamsulosin | 13 | $468 | $36 |
| Levothyroxine | 19 | $380 | $20 |
| Levofloxacin | 23 | $272 | $12 |
| Valsartan-Hydrochlorothiazide | 12 | $189 | $16 |
| Amoxicillin | 29 | $182 | $6 |
| Sulfamethoxazole-Trimethoprim | 19 | $166 | $9 |
| Isoniazid | 24 | $162 | $7 |
| Ciprofloxacin | 21 | $147 | $7 |
| Pantoprazole | 13 | $123 | $9 |
| Losartan | 17 | $107 | $6 |
| Simvastatin | 14 | $80 | $6 |
2015: 32 drugs
| Valcyte | 12 | $50,469 | $4,206 |
| Prezista | 24 | $29,689 | $1,237 |
| Atripla | 11 | $24,289 | $2,208 |
| Vancomycin | 42 | $18,525 | $441 |
| Truvada | 11 | $15,304 | $1,391 |
| Isentress | 12 | $13,589 | $1,132 |
| Intelence | 12 | $11,401 | $950 |
| Viread | 11 | $10,299 | $936 |
| Norvir | 23 | $8,731 | $380 |
| Seroquel Xr | 12 | $8,468 | $706 |
| Epivir | 11 | $4,177 | $380 |
| Fluconazole | 28 | $2,832 | $101 |
| Doxycycline Hyclate | 31 | $2,696 | $87 |
| Levofloxacin | 37 | $1,842 | $50 |
| Pyrazinamide | 14 | $1,723 | $123 |
| Rifampin | 23 | $1,608 | $70 |
| Doxycycline Monohydrate | 20 | $1,332 | $67 |
| Cephalexin | 51 | $818 | $16 |
| Amoxicillin-Clavulanate Potass | 32 | $790 | $25 |
| Levothyroxine | 35 | $766 | $22 |
| Tamsulosin | 16 | $752 | $47 |
| Ethambutol | 11 | $667 | $61 |
| Acyclovir | 22 | $603 | $27 |
| Nitrofurantoin Mono-Macro | 13 | $584 | $45 |
| Azithromycin | 11 | $512 | $47 |
| Valsartan-Hydrochlorothiazide | 11 | $451 | $41 |
| Amoxicillin | 34 | $272 | $8 |
| Sulfamethoxazole-Trimethoprim | 34 | $224 | $7 |
| Losartan | 14 | $118 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $113 | $9 |
| Isoniazid | 15 | $111 | $7 |
| Diazepam | 11 | $34 | $3 |
2014: 33 drugs
| Vancomycin | 17 | $35,587 | $2,093 |
| Prezista | 17 | $19,040 | $1,120 |
| Isentress | 13 | $13,772 | $1,059 |
| Intelence | 13 | $11,448 | $881 |
| Meropenem | 13 | $9,774 | $752 |
| Viread | 11 | $9,634 | $876 |
| Norvir | 24 | $9,215 | $384 |
| Piperacillin-Tazobactam | 14 | $5,697 | $407 |
| Crixivan | 11 | $5,045 | $459 |
| Epivir | 11 | $4,593 | $418 |
| Doxycycline Hyclate | 31 | $4,052 | $131 |
| Fluconazole | 24 | $2,220 | $93 |
| Acyclovir | 17 | $2,076 | $122 |
| Rifampin | 17 | $1,494 | $88 |
| Doxycycline Monohydrate | 26 | $1,491 | $57 |
| Amox Tr-Potassium Clavulanate | 36 | $1,252 | $35 |
| Azithromycin | 18 | $967 | $54 |
| Cephalexin | 42 | $948 | $23 |
| Levothyroxine | 33 | $663 | $20 |
| Valsartan-Hydrochlorothiazide | 11 | $414 | $38 |
| Isoniazid | 30 | $385 | $13 |
| Sulfamethoxazole-Trimethoprim | 49 | $369 | $8 |
| Levofloxacin | 28 | $331 | $12 |
| Amoxicillin | 21 | $303 | $14 |
| Losartan | 17 | $235 | $14 |
| Omeprazole | 12 | $167 | $14 |
| Ciprofloxacin | 12 | $163 | $14 |
| Mupirocin | 14 | $156 | $11 |
| Diphenoxylate-Atropine | 14 | $153 | $11 |
| Atorvastatin | 12 | $115 | $10 |
| Metformin | 11 | $108 | $10 |
| Triamcinolone Acetonide | 12 | $73 | $6 |
| Diazepam | 14 | $41 | $3 |
2013: 33 drugs
| Vancomycin | 18 | $30,278 | $1,682 |
| Prezista | 13 | $13,302 | $1,023 |
| Isentress | 13 | $13,066 | $1,005 |
| Itraconazole | 12 | $12,462 | $1,039 |
| Intelence | 13 | $10,586 | $814 |
| Invanz | 16 | $8,793 | $550 |
| Avelox | 15 | $6,568 | $438 |
| Norvir | 13 | $6,313 | $486 |
| Ceftriaxone | 13 | $5,975 | $460 |
| Acyclovir | 16 | $2,588 | $162 |
| Azithromycin | 36 | $2,337 | $65 |
| Rifampin | 28 | $2,007 | $72 |
| Doxycycline Hyclate | 17 | $1,857 | $109 |
| Fluconazole | 32 | $1,799 | $56 |
| Cephalexin | 51 | $1,045 | $20 |
| Ethambutol | 15 | $1,027 | $68 |
| Amox Tr-Potassium Clavulanate | 26 | $911 | $35 |
| Levofloxacin | 33 | $841 | $25 |
| Cefuroxime | 14 | $636 | $45 |
| Sulfamethoxazole-Trimethoprim | 56 | $618 | $11 |
| Amoxicillin | 29 | $536 | $18 |
| Valsartan-Hydrochlorothiazide | 11 | $417 | $38 |
| Levothyroxine | 27 | $410 | $15 |
| Ciprofloxacin | 24 | $387 | $16 |
| Omeprazole | 11 | $296 | $27 |
| Losartan | 15 | $284 | $19 |
| Atorvastatin | 14 | $191 | $14 |
| Warfarin | 16 | $146 | $9 |
| Metformin | 12 | $98 | $8 |
| Metoprolol | 12 | $98 | $8 |
| Diphenoxylate-Atropine | 13 | $93 | $7 |
| Glipizide | 12 | $50 | $4 |
| Diazepam | 13 | $41 | $3 |
Money from drug and device companies
$454 in 2024
| 2024 | 3 | 6 | None | $454 |
| 2023 | 1 | 1 | None | $24 |
| 2020 | 1 | 1 | None | $143 |
| 2019 | 2 | 2 | None | $147 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotissue Holdings | None | $303 | 4 payments
|
| MIMEDX Group | None | $137 | 1 payment
|
| Gilead Sciences | None | $14 | 1 payment
|
See all 6 published payments
| MIMEDX Group | Meals · 2024-12-18 | None | $137 |
| Biotissue Holdings | Meals · 2024-10-13 | None | $86 |
| Biotissue Holdings | Meals · 2024-10-13 | None | $19 |
| Biotissue Holdings | Meals · 2024-01-29 | None | $99 |
| Gilead Sciences | Meals · 2024-01-18 | None | $14 |
| Biotissue Holdings | Meals · 2024-01-08 | None | $99 |
See earlier years (2023, 2020, 2019)
2023: $24
| Merck Sharp & Dohme | None | $24 | 1 payment
|
2020: $143
| Smith+Nephew | Grafix Pl | $143 | 1 payment
|
2019: $147
| Smith+Nephew | Grafixpl | $134 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
Professional record
- NPI
- 1700955143
- Licence
- CA G22044California G22044: Current · expires 2027-09-30
- Trained
- New York Medical College, 1966
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G220440
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 2100 Forest Ave, #106, San Jose, CA, 95128
- NPI first listed
- 2006-11-07
- NPI last updated
- 2008-12-04
This is when the NPI record was last certified, not a medical board exam.